Natixis’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$697K Sell
1,175
-19,474
-94% -$9.7M ﹤0.01% 754
2025
Q4
$10.1M Buy
+20,649
New +$9.62M 0.04% 331
2025
Q3
Sell
-896
Closed -$257K 1243
2025
Q2
$257K Buy
+896
New +$268K ﹤0.01% 776
2025
Q1
Sell
-241
Closed -$85K 1197
2024
Q4
$85K Buy
+241
New +$88.6K ﹤0.01% 849
2024
Q3
Sell
-112
Closed -$35.7K 1127
2024
Q2
$35.7K Sell
112
-6,716
-98% -$1.78M ﹤0.01% 798
2024
Q1
$1.57M Sell
6,828
-88
-1% -$19.9K 0.01% 466
2023
Q4
$1.52M Buy
6,916
+6,211
+881% +$1.43M 0.01% 459
2023
Q3
$159K Sell
705
-4,679
-87% -$1.08M ﹤0.01% 738
2023
Q2
$1.19M Buy
5,384
+5,223
+3,244% +$1.16M 0.01% 512
2023
Q1
$36.1K Sell
161
-9,039
-98% -$2.23M ﹤0.01% 849
2022
Q4
$2.56M Sell
9,200
-45,800
-83% -$11.6M 0.02% 492
2022
Q3
$11.5M Buy
55,000
+41,200
+299% +$9.21M 0.05% 256
2022
Q2
$3.25M Sell
13,800
-110,500
-89% -$22.5M 0.01% 547
2022
Q1
$22.3M Buy
124,300
+46,100
+59% +$8.78M 0.08% 238
2021
Q4
$16.9M Buy
78,200
+3,200
+4% +$628K 0.06% 280
2021
Q3
$13.8M Buy
+75,000
New +$14.8M 0.05% 299
2019
Q3
Sell
-67,758
Closed -$5.29M 927
2019
Q2
$5.29M Buy
67,758
+30,178
+80% +$2.82M 0.04% 313
2019
Q1
$4.41M Buy
37,580
+18,821
+100% +$2.19M 0.03% 393
2018
Q4
$2.04M Buy
+18,759
New +$2.18M 0.02% 420
2017
Q2
Sell
-2,116
Closed -$286K 990
2017
Q1
$286K Buy
+2,116
New +$321K ﹤0.01% 722

Other funds holding UTHR